ARTICLE | Company News
XenoPort, NIH deal
September 22, 2014 7:00 AM UTC
XenoPort and NIH's National Institute on Alcohol Abuse and Alcoholism (NIAAA) partnered to conduct a clinical trial to evaluate Horizant gabapentin enacarbil to treat alcohol use disorder. XenoPort w...